Universe Pharmaceuticals Schedules Shareholder Meeting for Jan 2025
Ticker: UPC · Form: 6-K · Filed: Jan 30, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Jan 30, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting, legal-amendment
TL;DR
Uni Pharma (UPC) holding shareholder meeting Jan 2025 to vote on company charter changes. Watch for governance updates.
AI Summary
Universe Pharmaceuticals INC announced an Extraordinary General Meeting of Shareholders to be held in January 2025. The meeting will discuss and vote on proposed amendments to the company's Articles of Association. These amendments are intended to align with recent changes in Chinese corporate law and potentially improve corporate governance.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to influence company direction and approve significant changes like amendments to articles of association.
Risk Assessment
Risk Level: low — This filing is a routine corporate announcement regarding a shareholder meeting and proposed amendments, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the report
- January 2025 (date) — Month of the Extraordinary General Meeting of Shareholders
FAQ
What is the purpose of the Extraordinary General Meeting of Shareholders?
The meeting is being held to discuss and vote on proposed amendments to the company's Articles of Association.
When is the Extraordinary General Meeting of Shareholders scheduled to take place?
The meeting is scheduled for January 2025.
What is the primary reason for amending the Articles of Association?
The amendments are intended to align the Articles of Association with recent changes in Chinese corporate law.
What is the company's principal executive office address?
The company's principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China, 343100.
Under which form does the registrant file its annual reports?
The registrant files its annual reports under Form 20-F.
Filing Stats: 248 words · 1 min read · ~1 pages · Grade level 17.9 · Accepted 2025-01-30 08:00:09
Filing Documents
- ea0229115-6k_universe.htm (6-K) — 28KB
- ea022911501ex99-1_universe.htm (EX-99.1) — 146KB
- ea022911501ex99-2_universe.htm (EX-99.2) — 36KB
- togier_logo.jpg (GRAPHIC) — 24KB
- 0001213900-25-008083.txt ( ) — 244KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   Universe Pharmaceuticals INC. Date: January 30, 2025   By:   /s/ Gang Lai         Gang Lai         Chief Executive Officer 2